Ruth Adams Clinical Practice Educator LLR Sexual Health

Slides:



Advertisements
Similar presentations
Post-Abortion IUC Insertion Eleanor Drey, MD, EdM Assistant Clinical Professor Obstetrics, Gynecology and Reproductive Sciences University of California,
Advertisements

111 LESSON 3 Depo-IM and Sayana Press: Two formulas of the same contraceptive.
Injection for Medications
What’s New in Adolescent Contraception? Rachel S-D Fortune, MD, FAAP Medical Director, Newport Academy.
Sheffield Local Pharmaceutical Committee Supporting Community Pharmacy Pharmacy Sexual Health Services – Update October 2014 James.
Are you up with the LARCs? Dr Christine Roke National Medical Advisor, Family Planning March 2011.
The Family Planning Clinic. For each of the cases Consider the factors raised by the case Advise about options, including alternatives.
Preparation by : Ali Sayma
Contraceptive Options for Women and Couples with HIV Intrauterine Device (IUD or IUCD) Copper T-380A.
Subcutaneous Intramuscular Injections
1 Copyright © 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved. Assisting with Medications Chapter 35.
Intramuscular Injections
Introduction to Injections Administer and Monitor Medication in the Work Environment Topic 8 Intradermal.
INJECTABLES Nora A. Alkhudair. Injections Percutaneous introduction of a medicinal substance, fluid or nutrient into the body. (e. g. intradermal, subcutaneous,
LIigo&list=PLGg3x5v82SZxEq8bdRRRigVj _4qlG3qtm.
Injections Hana Svobodová
LESSON 1 What is DMPA?.
Community Pharmacy Sheffield Supporting Community Pharmacy Pharmacy Sexual Health Services – Update June 2015.
Mary Lyn Gaffield and Mario Festin Human Reproduction Team
Prevention and management of side effects. Found that too early, frequent and late childbirth and abortion is one of the major causes of maternal and.
Abnormal Uterine Bleeding Case Studies
Intrauterine contraception device
Chapter 11 Parenteral Administration: Intradermal, Subcutaneous, and Intramuscular Routes Mosby items and derived items © 2013, 2010, 2007, 2004 by Mosby,
FACT OR MYTH. A history of gonorrhea or chlamydia is a contraindication to an IUD MYTH.
Teresa Meenaghan RANP Haematology 16thOctober HAI.
Injections Hana Svobodová. Types of containers Medications for injection are supplied in several types of container : Vials Ampules Cartridges.
Inpatient Nexplanon Experience Amy H. Picklesimer, MD, MSPH Associate Professor Department of Obstetrics and Gynecology University of South Carolina -
Contraception in the over 40s Ruth Adams Clinical Educator Leicester Sexual Health.
CONTRACEPTION UPDATE 17 March 2016 Josephine Percival SRN MSc NIP PGA Med Ed FRT Nurse Consultant in Contraception East Sussex NHS Healthcare Trust
Emergency Contraception Ruth Adams Clinical Educator Leicester Sexual Health.
Long-acting Reversible Contraception
The photos in this PowerPoint may be freely used for educational or noncommercial purposes, provided that a photo credit is included. Expanding options.
Progestogen-only contraception
LESSON 9 How to counsel clients on Sayana Press self-injection
LARC methods 07/11/16 Background Choice Which larc and why? Scenarios
Contraception in the over 40’s
Preparing for OB Clinicals: Administering T-dap, Influenza and
Emergency Contraception
Larc Quiz!.
Clinical Medical Assisting
Mr Pratik N Shah MD MRCOG Clinical Director for Womens Services
Contraception IUC’s, Sterilization.
Self-injection Instructions
MTN-036 Study of Extended Duration Dapivirine Vaginal Ring for HIV Prevention How do I know if I’m Eligible to join? Women who join the study must.
Easily Missed Ectopic Pregnancy.
Background Registered Nurse and Midwife.
Quick update on contraception
Sayana Press A Training Presentation for Providers Version 4 July 2016
Introduction; Scope of Pharmacology Routes of Drug Administration
Contraception: The facts
LARC methods 04/12/17 Background Choice Which larc and why? Scenarios
Contraception in the over 40’s
Sexual Health in Primary Care
Dr K Dissanayake Bute House Medical Centre
Choosing a contraception that’s right for u
Choosing a contraception that’s right for u
Awareness of Long Acting Reversible Contraception in General Practice
Gingivitis can worsen during different phases of the life cycle:
GP Education Meeting September 2018
Contraceptive and Reproductive Technology
Alternative Injection Sites: Reducing Prone Restraint in Tier 4 CAMH’s Embedding a new culture within nursing through education.
Post Abortion Contraception
CONTRACEPTION POST ABORTION
EMERGENCY CONTRACEPTION SHumi Negesse, MD Assistant Professor, Adama hospital medical college Department of OBSTETRICS AND GYNECOLOGY.
SEXUAL HEALTH AND CONTRACEPTION SERVICE ASHCROFT SURGERY
GP / Nurse / HCP hours wasted = 43 HOURS
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial
Parenteral Medications
Parenteral Dosages Chapter 12
Presentation transcript:

Ruth Adams Clinical Practice Educator LLR Sexual Health LARC Update Ruth Adams Clinical Practice Educator LLR Sexual Health

Why use LARC?

Introducing Sayana Press

About Sayana Press S/C injection of 104mg in 0.65ml Medroxyprogesterone Acetate Product licence is for 13 weeks Has licence for self-administration In women with deep adipose tissue in the gluteal area, standard-length needles may not reach the muscle layer and SC DMPA or deltoid administration of IM DMPA should be considered. SC DMPA should be injected into the abdomen or anterior thigh.

Self Administration Saves women having to attend surgery every 3 months. Missing appointments can put women at risk of pregnancy Self-administration may reduce this risk. Women need training and must be supervised by a HCP when administering the first dose. They can then be given supply of three further injections and reviewed in surgery every year. Who is suitable?

Video http://www.sayanaanswers.co.uk/guide-to-self-injection

Practicalities of Self Administration HCP guides etc can be ordered at www.medisa.com Patient specific website www.sayanaanswers.co.uk Patient website allows to sign up for text reminder Sharps bins will be required at home

Introducing Jaydess

Comparison with Mirena 28mm width Silver Ring 30mm length 6 micrograms/24 hours Up to 3 years contraceptive cover Smallest IUS Insertion tube diameter 3.8mm levonorgestrel 20 micrograms/24 hours Up to 5 years contraceptive cover Treatment for HMB HRT for up to 4 years Insertion tube diameter 4.4mm 32mm width 32mm length

About Jaydess 90% of women with Jaydess have monthly menses No difference in reported hormonal side effects compared to Mirena. Found to be less painful to fit than Mirena Increasingly popular with young women who are nulliparous. Popular with women who want regular periods. Product license is for contraception only Includes risk management, programme management, different approach to complaints Next phase of board development being designed

Ectopic pregnancy with IUD/IUS Previous ectopic is UKMEC 1 Because risk of pregnancy is very low, risk of ectopic is also very low approx. 1 in 1000 at 5 years However of those pregnancies a higher proportion are ectopic some studies suggest 9% whilst others up to 53% Ectopic rate of Jaydess is currently 50% but expected to reduce due to small number of pregnancies in study

Any Questions?

Anecdotal evidence that history of one expulsion increases risk of subsequent expulsion Risk of ectopic pregnancy with any IUC at 5 years is approx. 1:1000